Author: Russo, Francesco Paolo; Piano, Salvatore; Bruno, Raffaele; Burra, Patrizia; Puoti, Massimo; Masarone, Mario; Montagnese, Sara; Ponziani, Francesca Romana; Petta, Salvatore; Aghemo, Alessio
Title: Italian association for the study of the liver position statement on SARS-CoV2 vaccination Cord-id: 5cjj4kbd Document date: 2021_4_30
ID: 5cjj4kbd
Snippet: The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver tr
Document: The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients.
Search related documents:
Co phrase search for related documents- abnormal liver and acute rejection: 1
- abnormal liver and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- abnormal liver and liver disease patient: 1
- abnormal liver and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- abnormal liver and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- abnormal liver and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abnormal liver and liver injury include: 1
- abnormal liver and liver transplant: 1, 2, 3, 4, 5, 6
- abnormal liver and liver transplantation: 1, 2, 3, 4, 5, 6, 7
- abnormal liver and lung disease: 1
- abnormal liver biochemistry and active treatment: 1
- abnormal liver biochemistry and liver disease: 1, 2, 3, 4, 5
- abnormal liver biochemistry and liver function: 1
- abnormal liver biochemistry and liver injury: 1, 2, 3, 4
- abnormal liver biochemistry and liver transplantation: 1
- active arm and additional study: 1, 2, 3
- active arm and liver disease: 1
Co phrase search for related documents, hyperlinks ordered by date